NASDAQ: BGXXBright Green Corp Stock
$0.97+0.05 (+5.43%)
Updated Mar 24, 2023
BGXX Price
$0.97
Fair Value Price
N/A
Market Cap
$164.26M
52 Week Low
$0.35
52 Week High
$58.00
P/E
N/A
P/B
12.5x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.37
Operating Cash Flow
N/A
Beta
0.34
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BGXX Overview
Bright Green Corporation grows, manufactures, and sells cannabis and cannabis-related products legally under federal and state laws for research, pharmaceutical applications, and export. The company was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BGXX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BGXX is poor value based on its book value relative to its share price (12.5x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.79x)
P/B vs Industry Valuation
BGXX's short-term assets ($4.15M) exceed its short-term liabilities ($2.82M)
Short-term Liabilities Financials
BGXX's short-term assets ($4.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more BGXX due diligence checks available for Premium users.
Be the first to know about important BGXX news, forecast changes, insider trades & much more!
BGXX News
Valuation
BGXX fair value
Fair Value of BGXX stock based on Discounted Cash Flow (DCF)
Price
$0.97
Fair Value
$0.93
Overvalued by
4.85%
BGXX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
18.14x
Market
21.37x
BGXX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
12.5x
Industry
1.79x
BGXX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BGXX's financial health
Profit margin
Revenue
$0.0
Net Income
-$5.8M
Profit Margin
0%
Assets to liabilities
Assets
$18.0M
Liabilities
$4.9M
Debt to equity
0.37
BGXX's short-term assets ($4.15M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BGXX's short-term assets ($4.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BGXX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$804.2k
Investing
-$4.4M
Financing
$9.1M
BGXX vs Pharmaceutical Stocks
Bright Green Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.